| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |